Facebook
Twitter
LinkedIn
ForwardPulse - Don’t Stick with the STATUS Quo: Management of Super Refractory Status Epilepticus_enduring
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Super refractory status epilepticus is associated with high morbidity and mortality and optimal therapies are unknown. This education plans to review current literature on therapies for super refractory status epilepticus.
Target Audience
Pharmacist
Learning Objectives
1. Define status epilepticus types and initial management strategies
2. Discuss literature regarding treatment strategies in super refractory status epilepticus (SRSE)
3. Recognize important patient factors affecting SRSE management
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slide.pptx | 464.46 KB |
 PULSE Abstract MM.docx | 24.72 KB |
| Pulse 8-24-22.docx | 17.2 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Super refractory status epilepticus is associated with high morbidity and mortality and optimal therapies are unknown. This education plans to review current literature on therapies for super refractory status epilepticus.
Madeline Mitchell, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.